Document is current
Any future updates will be listed below
-
Authors
Herwig, Melissa https://orcid.org/0000-0003-3245-5504
Sieme, Marcel https://orcid.org/0000-0002-8253-879X
Kovács, Andrea
Khan, Muchtiar
Mügge, Andreas https://orcid.org/0000-0001-9548-6995
Schmidt, Wolfgang E.
Elci, Ferhat
Sasidharan, Shan https://orcid.org/0000-0002-1670-3638
Haldenwang, Peter https://orcid.org/0000-0003-1884-3498
Wintrich, Jan https://orcid.org/0000-0001-6518-1453
Sasko, Benjamin https://orcid.org/0000-0001-8157-9875
Akin, Ibrahim https://orcid.org/0000-0003-1974-6147
Domokos, Máthé https://orcid.org/0000-0001-7343-0413
Paneni, Francesco https://orcid.org/0000-0001-6483-7844
El-Battrawy, Ibrahim https://orcid.org/0000-0002-0139-1045
Varga, Zoltán V. https://orcid.org/0000-0002-2758-0784
Saraiva, Francisca https://orcid.org/0000-0001-7961-9962
Leite-Moreira, Adelino F. https://orcid.org/0000-0001-7808-3596
Ferdinandy, Péter https://orcid.org/0000-0002-6424-6806
van Heerebeek, Loek https://orcid.org/0000-0001-6718-2871
Falcão-Pires, Inês https://orcid.org/0000-0003-1937-3782
Hamdani, Nazha https://orcid.org/0000-0002-3053-0008
-
Funding
Funding for this research was provided by:
Hector Stiftung (MED1814, M2401)
Innovation Forum program of the Medical Faculty, RUB (IF-023-22)
Deutsche Herzstiftung (F/17/23)
Else Kröner-Fresenius-Stiftung (RRF-2.3.1-21-2022-00003)
EU’s Horizon 2020 research and innovation program (739593, 739593)
National Research, Development and Innovation Office (NKFIH) of Hungary (FK134751)
Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund (TKP2021-EGA-23)
Deutsche Forschungsgemeinschaft (HA 7512/2-4)
- License Information
-
More Information
Article History
Received: 19 February 2025
Accepted: 19 April 2025
First Online: 13 May 2025
Declarations
:
: This study was approved by the Ethics Committee of ULS São João Hospital (Ref 109/2022) following the Declaration of Helsinki. Informed consent was obtained from all patients.
: Not applicable.
: The authors declare that they have no competing interests. P.F. is the founder and CEO of Pharmahungary Group, a group of R&D companies. Francesco Paneni and Era Gorica manage the collection “Cardiometabolic HFpEF with focus on type 2 diabetes mellitus” and the co-author Francesco Paneni is also an Associate Editor of Cardiovascular Diabetology. They haven’t been involved in the peer review of this article.
